About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good. Although parents reported good adherence to therapy, a new ...
Crunchyroll, the global brand fueling anime fandom, is now part of an FDA-approved and doctor-prescribed VR treatment for kids with lazy eye. Through a new collaboration with digital health company ...
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 / ...
Please provide your email address to receive an email when new articles are posted on . NovaSight announced that it is launching CureSight, its digital therapy for amblyopia, to the U.S. market this ...
CAMBRIDGE, Mass., Oct. 28, 2025 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced a collaboration with ...
The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 years with amblyopia, according to a press release from Luminopia. The therapy, which ...
SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or turned eye) or ...
Eye-Tracking-Based Digital Amblyopia Therapy Device This new development follows the inclusion of CureSight's amblyopia therapy under Anthem's updated medical policy (MED.00145 - Digital Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback